Positives

• P-5-P (pyridoxal-5-phosphate) is the active coenzyme form of vitamin B6, bypassing the liver activation step that regular pyridoxine requires — relevant for Long COVID and ME/CFS patients with overlapping liver enzyme dysfunction or impaired methylation RTHM.
  
  
• Long COVID and ME/CFS patients show severely depleted Bacteroides populations, the gut bacteria responsible for synthesizing endogenous P5P; supplementing the active form bypasses this gut-microbiome bottleneck RTHM.
  
  
• B-vitamin interventions including active B6 produce clinically relevant decreases in homocysteine, with earlier landmark MRI trials showing lowering homocysteine reduced brain atrophy rates in older adults RTHM.
  
  

Negatives

• Patients commonly ask whether P5P at 80 mg per day is safe after experiencing or fearing neuropathy, with multiple Mayo Clinic Connect threads documenting these concerns Mayo Clinic Connect.
• Peripheral neuropathy can develop from low-dose B6, with patients reporting tingling, burning, and numbness in hands and feet even at supplement-label doses Mayo Clinic Connect.
• Patients on high-dose P5P (>100-200 mg/day) commonly develop the same sensory neuropathy as pyridoxine, and recovery can take months to years with permanent damage possible Ageimmune.

Hurdles & Side Effects

• High-dose B6 (especially the inactive pyridoxine form) at chronic doses above 50 mg/day can cause peripheral neuropathy that may persist after discontinuation; PLP-form supplements are preferred specifically because they show minimal neurotoxicity in cell viability tests RTHM.